Patents by Inventor Richard Lewis Momparler

Richard Lewis Momparler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytosine nucleoside analogs and isoflavones and uses thereof
    Patent number: 7985738
    Abstract: Methods, uses, compositions and kits relating to the inhibition and/or prevention of undesirable cell proliferation, and prevention and/or treatment of diseases or disorders associated with such proliferation, such as cancer, using a cytosine nucleoside analog such as 5-aza-2?-deoxycytidine and an isoflavone such as genistein, are described.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: July 26, 2011
    Assignee: Institut National de la Recherche Scientifique
    Inventors: Michel Charbonneau, Noel Jean-Marie Raynal, Richard Lewis Momparler, Louise F. Momparler
  • CYTOSINE NUCLEOSIDE ANALOGS AND ISOFLAVONES AND USES THEREOF
    Publication number: 20080293651
    Abstract: Methods, uses, compositions and kits relating to the inhibition and/or prevention of undesirable cell proliferation, and prevention and/or treatment of diseases or disorders associated with such proliferation, such as cancer, using a cytosine nucleoside analog and an isoflavone, are described.
    Type: Application
    Filed: May 23, 2008
    Publication date: November 27, 2008
    Applicant: INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Michel Charbonneau, Noel Jean-Marie Raynal, Richard Lewis Momparler, Louise F. Momparler
  • Methods of treatment
    Patent number: 5891866
    Abstract: A method of inducing inhibition or loss of cell proliferation in solid tumors utilizing a Vitamin D.sub.3 analog, as well as a method of inducing loss of cell proliferation in solid tumors utilizing trans retinoic acid and a Vitamin D.sub.3 analog.In another aspect, a method of inducing inhibition or loss of cell proliferation in solid tumors utilizing a Vitamin D.sub.3 metabolite, as well as a method of inducing loss of cell proliferation in solid tumors utilizing trans retinoic acid and a Vitamin D.sub.3 metabolite.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: April 6, 1999
    Assignee: Hoffman-La Roche Inc.
    Inventors: Benoit Thomas Dore, Richard Lewis Momparler, Milan Radoje Uskokovic
  • Methods of treatment
    Patent number: 5856317
    Abstract: A method of inducing inhibition or loss of cell proliferation in solid tumors utilizing a Vitamin D.sub.3 analog, as well as a method of inducing loss of cell proliferation in solid tumors utilizing trans retinoic acid and a Vitamin D.sub.3 analog.In another aspect, a method of inducing inhibition or loss of cell proliferation in solid tumors utilizing a Vitamin D.sub.3 metabolite, as well as a method of inducing loss of cell proliferation in solid tumors utilizing trans retinoic acid and a Vitamin D.sub.3 metabolite.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: January 5, 1999
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Benoit Thomas Dore, Richard Lewis Momparler, Milan Radoje Uskokovic